Aurora Spine Corporation
ASAPF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.97 | 0.51 | 0.30 | 0.01 |
| FCF Yield | 0.83% | 0.86% | -1.86% | 0.84% |
| EV / EBITDA | 140.87 | 163.30 | -573.84 | -69.31 |
| Quality | ||||
| ROIC | -0.99% | -1.72% | -3.36% | -5.48% |
| Gross Margin | 25.47% | 62.24% | 58.02% | 23.24% |
| Cash Conversion Ratio | -2.42 | -1.01 | 0.46 | -0.28 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.25% | 9.81% | 7.68% | 5.38% |
| Free Cash Flow Growth | -4.60% | 141.33% | -294.37% | -59.50% |
| Safety | ||||
| Net Debt / EBITDA | 20.89 | 24.82 | -82.12 | -5.15 |
| Interest Coverage | -1.83 | -3.09 | -6.24 | -10.18 |
| Efficiency | ||||
| Inventory Turnover | 0.86 | 0.44 | 0.49 | 0.55 |
| Cash Conversion Cycle | 128.57 | 174.23 | 168.62 | 158.43 |